tradingkey.logo
tradingkey.logo

AVITA Medical Inc

RCEL
3.440USD
+0.010+0.29%
終値 12/23, 16:00ET15分遅れの株価
524.48M時価総額
損失額直近12ヶ月PER

AVITA Medical Inc

3.440
+0.010+0.29%

詳細情報 AVITA Medical Inc 企業名

AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.

AVITA Medical Incの企業情報

企業コードRCEL
会社名AVITA Medical Inc
上場日Mar 18, 2012
最高経営責任者「CEO」Vance (Cary G)
従業員数260
証券種類Ordinary Share
決算期末Mar 18
本社所在地28159 Avenue Stanford
都市VALENCIA
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号91355
電話番号16613679170
ウェブサイトhttps://www.avitamedical.com/
企業コードRCEL
上場日Mar 18, 2012
最高経営責任者「CEO」Vance (Cary G)

AVITA Medical Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
49.63K
+67.49%
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
27.71K
--
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
20.61K
--
Dr. Michael Tarnoff Tarnoff, M.D.
Dr. Michael Tarnoff Tarnoff, M.D.
Independent Director
Independent Director
--
--
Ms. Jessica Ekeberg
Ms. Jessica Ekeberg
Director - Investor Relations
Director - Investor Relations
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
Mr. David O'Toole
Mr. David O'Toole
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Non-Executive Lead Independent Director
Non-Executive Lead Independent Director
--
--
Ms. Nicole Linda Kelsey, J.D.
Ms. Nicole Linda Kelsey, J.D.
Chief Legal and Compliance Officer, Corporate Secretary
Chief Legal and Compliance Officer, Corporate Secretary
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
49.63K
+67.49%
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
27.71K
--
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
20.61K
--
Dr. Michael Tarnoff Tarnoff, M.D.
Dr. Michael Tarnoff Tarnoff, M.D.
Independent Director
Independent Director
--
--
Ms. Jessica Ekeberg
Ms. Jessica Ekeberg
Director - Investor Relations
Director - Investor Relations
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
会社から関連データがまだ開示されていません。
地域別USD
会社名
収益
比率
United States
17.90M
97.17%
Japan
427.00K
2.32%
United Kingdom
55.00K
0.30%
Australia
40.00K
0.22%
European Union (Region)
0.00
0.00%
事業別
地域別
会社から関連データがまだ開示されていません。

株主

更新時刻: Thu, Dec 4
更新時刻: Thu, Dec 4
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
4.48%
BlackRock Institutional Trust Company, N.A.
3.51%
State Street Investment Management (US)
1.39%
Geode Capital Management, L.L.C.
1.09%
Northern Trust Investments, Inc.
0.52%
他の
89.02%
株主統計
株主統計
比率
The Vanguard Group, Inc.
4.48%
BlackRock Institutional Trust Company, N.A.
3.51%
State Street Investment Management (US)
1.39%
Geode Capital Management, L.L.C.
1.09%
Northern Trust Investments, Inc.
0.52%
他の
89.02%
種類
株主統計
比率
Investment Advisor
10.47%
Investment Advisor/Hedge Fund
4.55%
Individual Investor
0.80%
Research Firm
0.74%
Hedge Fund
0.62%
Pension Fund
0.25%
Bank and Trust
0.24%
Venture Capital
0.08%
他の
82.25%

機関投資家保有株

更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
206
7.68M
25.17%
-2.00M
2025Q2
210
7.20M
27.22%
-1.82M
2025Q1
225
7.35M
27.79%
-1.89M
2024Q4
218
6.78M
25.72%
-2.16M
2024Q3
215
6.40M
24.41%
-2.52M
2024Q2
210
6.40M
24.65%
-3.74M
2024Q1
216
7.55M
29.29%
-2.27M
2023Q4
213
7.36M
28.65%
-3.81M
2023Q3
208
8.37M
32.77%
-2.77M
2023Q2
206
8.16M
32.08%
-1.08M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
1.45M
5.45%
+16.54K
+1.15%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
1.74M
6.53%
+13.93K
+0.81%
Jun 30, 2025
State Street Investment Management (US)
528.78K
1.99%
+1.83K
+0.35%
Jun 30, 2025
Geode Capital Management, L.L.C.
618.34K
2.32%
-1.36K
-0.22%
Jun 30, 2025
Northern Trust Investments, Inc.
242.03K
0.91%
-10.13K
-4.02%
Jun 30, 2025
Millennium Management LLC
369.19K
1.39%
+357.21K
+2980.45%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Tue, Dec 2
更新時刻: Tue, Dec 2
銘柄名
比率
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
iShares Micro-Cap ETF
0.01%
iShares Core S&P Total U.S. Stock Market ETF
0%
ProShares UltraPro Russell2000
0%
iShares Russell 3000 ETF
0%
Proshares Ultra Russell 2000
0%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
Global X Russell 2000 ETF
0%
Direxion Daily S&P Biotech Bull 3X Shares
0%
詳細を見る
Goldman Sachs ActiveBeta US Small Cap Equity ETF
比率0.02%
iShares Micro-Cap ETF
比率0.01%
iShares Core S&P Total U.S. Stock Market ETF
比率0%
ProShares UltraPro Russell2000
比率0%
iShares Russell 3000 ETF
比率0%
Proshares Ultra Russell 2000
比率0%
iShares Russell 2000 ETF
比率0%
iShares Russell 2000 Growth ETF
比率0%
Global X Russell 2000 ETF
比率0%
Direxion Daily S&P Biotech Bull 3X Shares
比率0%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

AVITA Medical Incの上位5名の株主は誰ですか?

AVITA Medical Incの上位5名の株主は以下のとおりです。
The Vanguard Group, Inc.は1.45M株を保有しており、これは全体の5.45%に相当します。
BlackRock Institutional Trust Company, N.A.は1.74M株を保有しており、これは全体の6.53%に相当します。
State Street Investment Management (US)は528.78K株を保有しており、これは全体の1.99%に相当します。
Geode Capital Management, L.L.C.は618.34K株を保有しており、これは全体の2.32%に相当します。
Northern Trust Investments, Inc.は242.03K株を保有しており、これは全体の0.91%に相当します。

AVITA Medical Incの株主タイプ上位3種は何ですか?

AVITA Medical Incの株主タイプ上位3種は、
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)

AVITA Medical Inc(RCEL)の株式を保有している機関の数はいくつですか?

2025Q3時点で、AVITA Medical Incの株式を保有している機関は206社あり、保有株式の総市場価値は約7.68Mで、全体の25.17%を占めています。2025Q2と比較して、機関の持ち株は-2.05%増加しています。

AVITA Medical Incの最大の収益源は何ですか?

FY2025Q2において、--部門がAVITA Medical Incにとって最大の収益を生み出しており、その金額は--で、全収益の--%を占めています。
KeyAI